THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
98,063,357
Share change
-1,065,563
Total reported value
$1,541,530,977
Put/Call ratio
5571%
Price per share
$15.72
Number of holders
108
Value change
-$15,533,663
Number of buys
60
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q1 2015

As of 31 Mar 2015, THERAVANCE INC - COMMON STOCK (THRX) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,063,357 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BlackRock Fund Advisors, OPPENHEIMER FUNDS INC, PERRY CORP, STATE STREET CORP, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, and Litespeed Management, L.L.C.. This page lists 108 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.